Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion-Reference-Cited by-同舟云学术

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion

Published:2017-07-10 Issue:4 Volume:20 Page:565-568
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Itäinen Saga¹,Lehto Mika¹,Vasankari Tuija²,Mustonen Pirjo³,Kotamäki Mervi¹,Numminen Anna³,Lahtela Heli⁴,Bah Aissa⁵,Hartikainen Juha⁵,Hekkala Anna-Mari⁶,Airaksinen Juhani K E²

Affiliation:

1. Heart and Lung Center, Helsinki University Hospital and University of Helsinki

2. Heart Center, Turku University Hospital and University of Turku

3. Central Finland Health Care District

4. North-Kymi Hospital

5. Heart Center, Kuopio University Hospital, University of Eastern Finland

6. Helsinki City Hospital

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/20/4/565/24524754/eux116.pdf

Reference22 articles.

1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Europace,2016

2. Stroke severity in atrial fibrillation. The Framingham Study;Lin;Stroke,1996

3. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis;Hart;Ann Intern Med,1999

4. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Camm;Europace,2010

5. Anticoagulation for cardioversion of atrial fibrillation;Weinberg;Am J Cardiol,1989

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elective Direct Current Cardioversion of Atrial Fibrillation: Silent Brain Infarction and Health-Related Quality of Life;Cardiology;2024-08-01

2. Thromboembolic and bleeding complications after elective cardioversion of atrial fibrillation: a nationwide cohort study;Europace;2024-06

3. Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures;Journal of the American College of Cardiology;2024-01

4. Is there a reduced confidence towards direct oral anticoagulants compared to vitamin K antagonists in patients scheduled for an elective electrical cardioversion? The results of the BLITZ-AF study;International Journal of Cardiology;2023-11

5. Direct oral anticoagulants for electrical cardioversion;Cardiovascular Therapy and Prevention;2021-07-17